Semnur Pharmaceuticals, Inc. Cash and Cash Equivalents
Semnur Pharmaceuticals, Inc. (SMNR) had Cash and Cash Equivalents of $39.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-10
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $39.00K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $103.00K.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $20.00K.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $85.00K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $20.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $85.00K 10-Q · filed 2025-11-12 |
| 2024-12-31 | $12.00K S-1 · filed 2026-05-12 |
| 2024-03-31 | $1.01K 10-Q · filed 2024-05-22 |
| 2023-12-31 | $204.46K 10-Q · filed 2024-05-22 |
| 2023-09-30 | $13.46K 10-Q · filed 2023-11-09 |
| 2022-12-31 | $819.75K 10-K · filed 2024-04-01 |